Search

Your search keyword '"Scallan, Ciaran"' showing total 181 results

Search Constraints

Start Over You searched for: Author "Scallan, Ciaran" Remove constraint Author: "Scallan, Ciaran"
181 results on '"Scallan, Ciaran"'

Search Results

1. A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results

2. The Clinical Frailty Scale for Risk Stratification in Patients With Fibrotic Interstitial Lung Disease

4. Integration and Application of Radiologic Patterns From Clinical Practice Guidelines on Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis

5. Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results

8. Lung imaging patterns in connective tissue disease–associated interstitial lung disease impact prognosis and immunosuppression response

9. The clinical frailty scale is associated with progression of fibrotic interstitial lung disease – a multicentre cohort study.

11. Treatment of idiopathic pulmonary fibrosis: an update on emerging drugs in phase II & III clinical trials

14. Vascular-Parenchymal Crosstalk Promotes Lung Fibrosis Through BMPR2 Signaling

15. 1974. Title: A novel low-dose self-amplifying mRNA vaccine (GRT-R910) induces strong and broad boost in cellular and humoral immune response following primary series with a chimpanzee adenovirus SARS-CoV-2 vaccination

17. MIT CAACB Risk Assessment Case Study: Assessing Virus Cross-Contamination Risk between Two Simultaneous Processes in an Open Biomanufacturing Facility

18. GRT-R910: a self-amplifying mRNA SARS-CoV-2 vaccine boosts immunity for ≥6 months in previously-vaccinated older adults.

19. Vascular–Parenchymal Cross-Talk Promotes Lung Fibrosis through BMPR2 Signaling.

21. Abstract 3578: Optimization of shared neoantigen vaccine design to increase vaccine potency: From bench to bedside and back

22. Abstract 4159: Lower doses of self-amplifying mRNA drive superior neoantigen-specific CD8 T cell responses in cancer patients versus high doses

25. Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry

26. Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry

27. Connective-Tissue Growth Factor Contributes to TGF-β1–induced Lung Fibrosis

28. Medical treatments for idiopathic pulmonary fibrosis: a systematic review and network meta-analysis

29. A self-amplifying mRNA COVID-19 vaccine drives potent and broad immune responses at low doses that protects non-human primates against SARS-CoV-2

33. Sildenafil for idiopathic pulmonary fibrosis: A systematic review and meta-analysis

36. Connective-Tissue Growth Factor Contributes to TGF-β1–induced Lung Fibrosis.

41. Role of human-milk lactadherin in protection against symptomatic rotavirus infection

44. AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B

46. 275. FACTORS ASSOCIATED WITH DISEASE PROGRESSION IN PATIENTS WITH MYELOPEROXIDASE-ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-RELATED PULMONARY FIBROSIS

47. Recurrent Pulmonary Fibrosis in a Lung Allograft Secondary to Antisynthetase Syndrome.

48. Abstract 724: A novel heterologous prime boost vaccine system drives tumor specific and potent CD8 T cell responses for cancer immunotherapy

49. Bronchoalveolar Lavage Fluid Cellular Analysis and Radiologic Patterns in Patients With Fibrotic Interstitial Lung Disease

50. What’s in a Name? Factors Associated with Documentation and Evaluation of Incidental Pulmonary Nodules

Catalog

Books, media, physical & digital resources